Abstract P3-13-02: Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
van der Noordaa, ME, Vrancken Peeters, M-JM, Ioan, I, Loo, CE, van Urk, J, van Werkhoven, E, Voorthuis, R, Wiersma, T, Groen, E, Rutgers, ET, van Duijnhoven, FH
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article